全文获取类型
收费全文 | 1614479篇 |
免费 | 135607篇 |
国内免费 | 4076篇 |
专业分类
耳鼻咽喉 | 21729篇 |
儿科学 | 53123篇 |
妇产科学 | 46361篇 |
基础医学 | 229083篇 |
口腔科学 | 47506篇 |
临床医学 | 142778篇 |
内科学 | 315872篇 |
皮肤病学 | 34271篇 |
神经病学 | 130939篇 |
特种医学 | 65612篇 |
外国民族医学 | 480篇 |
外科学 | 245723篇 |
综合类 | 43370篇 |
现状与发展 | 5篇 |
一般理论 | 545篇 |
预防医学 | 123838篇 |
眼科学 | 36836篇 |
药学 | 123223篇 |
13篇 | |
中国医学 | 4391篇 |
肿瘤学 | 88464篇 |
出版年
2018年 | 15390篇 |
2016年 | 13527篇 |
2015年 | 15914篇 |
2014年 | 21721篇 |
2013年 | 32430篇 |
2012年 | 43975篇 |
2011年 | 46348篇 |
2010年 | 27486篇 |
2009年 | 26298篇 |
2008年 | 44110篇 |
2007年 | 46367篇 |
2006年 | 46982篇 |
2005年 | 45491篇 |
2004年 | 44849篇 |
2003年 | 43032篇 |
2002年 | 42098篇 |
2001年 | 76268篇 |
2000年 | 78771篇 |
1999年 | 66707篇 |
1998年 | 17942篇 |
1997年 | 16512篇 |
1996年 | 16463篇 |
1995年 | 16131篇 |
1994年 | 15164篇 |
1993年 | 14287篇 |
1992年 | 55499篇 |
1991年 | 53839篇 |
1990年 | 52621篇 |
1989年 | 50877篇 |
1988年 | 47226篇 |
1987年 | 46565篇 |
1986年 | 44281篇 |
1985年 | 42842篇 |
1984年 | 32000篇 |
1983年 | 27524篇 |
1982年 | 16090篇 |
1981年 | 14375篇 |
1980年 | 13491篇 |
1979年 | 30418篇 |
1978年 | 21020篇 |
1977年 | 17693篇 |
1976年 | 16648篇 |
1975年 | 17516篇 |
1974年 | 21450篇 |
1973年 | 20643篇 |
1972年 | 18842篇 |
1971年 | 17754篇 |
1970年 | 16270篇 |
1969年 | 15250篇 |
1968年 | 13935篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Kinase alterations are increasingly recognised as oncogenic drivers in mesenchymal tumours. Infantile fibrosarcoma and the related renal tumour, congenital mesoblastic nephroma, were among the first solid tumours shown to harbour recurrent tyrosine kinase fusions, with the canonical ETV6::NTRK3 fusion identified more than 20 years ago. Although targeted testing has long been used in diagnosis, the advent of more robust sequencing techniques has driven the discovery of kinase alterations in an array of mesenchymal tumours. As our ability to identify these genetic alterations has improved, as has our recognition and understanding of the tumours that harbour these alterations. Specifically, this study will focus upon mesenchymal tumours harbouring NTRK or other kinase alterations, including tumours with an infantile fibrosarcoma-like appearance, spindle cell tumours resembling lipofibromatosis or peripheral nerve sheath tumours and those occurring in adults with a fibrosarcoma-like appearance. As publications describing the histology of these tumours increase so, too, do the variety kinase alterations reported, now including NTRK1/2/3, RET, MET, RAF1, BRAF, ALK, EGFR and ABL1 fusions or alterations. To date, these tumours appear locally aggressive and rarely metastatic, without a clear link between traditional features used in histological grading (e.g. mitotic activity, necrosis) and outcome. However, most of these tumours are amenable to new targeted therapies, making their recognition of both diagnostic and therapeutic import. The goal of this study is to review the clinicopathological features of tumours with NTRK and other tyrosine kinase alterations, discuss the most common differential diagnoses and provide recommendations for molecular confirmation with associated treatment implications. 相似文献
2.
3.
4.
5.
Qian Zhang Larry D. Mesner Gina M. Calabrese Naomi Dirckx Zhu Li Angela Verardo Qian Yang Robert J. Tower Marie-Claude Faugere Charles R. Farber Thomas L. Clemens 《The Journal of clinical investigation》2021,131(7)
Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass. 相似文献
6.
7.
8.
目的:评价不同缺牙间隙大小对上前牙区连续缺牙伴水平骨量不足、行水平骨增量延期种植的临床效果影响.方法:回顾性分析2013年1月~2019年6月期间,于烟台市口腔医院种植科就诊,上颌前牙连续缺失,行水平骨增量延期种植的患者,根据缺牙间隙分为两组,A组为2颗牙连续缺失,B组为3~6颗牙连续缺失.通过Mimics软件重建骨增量区3D模型,测量骨增量的体积及宽度;通过Image J软件测量平行投照根尖片种植体周围边缘骨丧失高度.使用SPSS 26.0软件,对测得的结果进行统计分析,P<0.05为差异具有统计学意义.结果:纳入44例患者,年龄18~60(平均38.52±12.56)岁.共计122个位点,植入94枚种植体,其中A组44枚,B组50枚.A、B组每牙位骨增量体积差异无统计学意义(P>0.05);A组每牙位骨增量宽度小于B组每牙位骨增量宽度(P<0.05);种植体周围骨质丧失高度随时间变化而增加(P<0.05);组别对种植体近中及远中骨边缘丧失高度的影响差异无统计学意义(P>0.05).结论:美学区水平骨增量延期种植可获得满意的临床效果,缺牙间隙对对骨增量体积及种植体周围边缘骨质稳定性无影响. 相似文献
9.
Yuxiang Ma Wenfeng Fang Hongyun Zhao Sai Praneeth Bathena Amol Tendolkar Jennifer Sheng Li Zhang 《The oncologist》2021,26(4):e549-e566
Lessons Learned
- The overall safety profiles of ipilimumab 3 mg/kg and 10 mg/kg administered every 3 weeks, were consistent between Chinese patients with solid tumors in the current study and patients from previous U.S. ipilimumab monotherapy studies. No new safety signals were identified.
- The mean systemic exposures to ipilimumab (assessed by first dose area under the curve during the dosing interval and maximum serum concentration) were numerically lower in the Chinese patient population than in U.S. patients for both 3 mg/kg and 10 mg/kg doses; however, the range of serum concentrations in the Chinese and U.S. populations overlapped (3 mg/kg and 10 mg/kg), suggesting that ipilimumab pharmacokinetics was ethnically insensitive in this study.
10.